P&G to acquire supplement brand Thorne for $3.8 billion

Published Aug 4, 05:31 PM UTC

Procter & Gamble (P&G) announced on August 4, 2026, that it will acquire supplement brand Thorne for $3.8 billion from L Catterton's Flagship Fund. The deal, expected to close later this year pending regulatory approvals, expands P&G's health and wellness division, which already includes Metamucil, Align Probiotic, and New Chapter. Thorne, founded in 1984, generated over $500 million in annual revenue in 2025. The acquisition represents a significant return for L Catterton, which bought Thorne for $680 million in 2023. P&G CEO Shailesh Jejurikar announced the deal on CNBC, noting that consumers under 40 account for the largest share of Thorne's sales. The move follows broader industry trends, with Unilever acquiring Grüns and Nestlé reviewing its supplement lines. P&G stock rose about 1% on the announcement day.